Menu

Trending event

Konstantin Linnik, Ph.D. speaks on IP issues facing development and commercialization of antibody therapeutics

Print PDF
05.07.2015

Konstantin Linnik, Ph.D., a partner in the firm's Intellectual Property Department, presented at the Cambridge Health Institute’s Essential Protein Engineering Summit (PEGS), which is considered the premier event for antibody and protein science research and the biologics industry. The conference, held in Boston, hosted over 1,800 attendees from more than 30 countries. Konstantin’s talk was entitled “Antibody Therapeutics: Charting a Course in The Rough Seas of Intellectual Property.” Antibody therapeutics is a growing field in biotech and is considered to be the future of cancer treatment.

More Events >